本课题为进一步研制LMWH口服给药系统奠定了理论基础和实验依据。
The study provided the theoretical foundation and experiment evidence for preparing oral drug delivery system of LMWH.
本发明涉及脂溶性二氢吡啶类钙离子拮抗剂的固体自乳化口服给药系统及其制备方法。
The invention relates to a solid self-emulsifying oral administration system of a fat-soluble dihydropyridine calcium ion antagonist and a preparation method thereof.
这些给药系统的口服制剂的组成和与药物相关的生物药剂学方面已经进行了广泛的研究。
The formulation and drug-related biopharmaceutical aspects of these systems that govern oral absorption have been widely studied.
目的：考察甲硝唑微囊口服结肠定位给药系统的制备工艺。
OBJECTIVE To investigate preparation method for the oral colon specific drug delivery system.
背景与目的：口服结肠靶向给药系统(OCDDS)是一种将药物定位释放于结肠的靶向制剂。
Background and Objective: OCDDS (Oral Colon-specific drug delivery system) is a kind of drug target delivery systems, which can deliver drug at colon.
此外，由于中药对肠道疾病的特殊作用，口服结肠靶向给药系统也是中药靶向给药的一个重要部分。
In addition, due to the specific actions of CMM on intestinal diseases, oral colon targeting drug delivery system is considered substantials for TODDSs of CMM.
口服液体控释给药系统是一种新型药物传递系统，因其存在物理不稳定性，所以能上市的品种较少。
Oral liquid drug controlled release system (OLCRS) is a new drug delivery system. But only a few has been come into the market due to the physical instability.
作为一种新型给药系统，纳米粒在口服给药方面具有广阔的开发及应用前景。
Recent studies of this technology is reviewed in the respects of preparation methods, surface modifications, drug release and pharmaceutical applications, implying a prosperous future of development.
利用非微粒脂质给药系统，药物不必经过溶出的步骤，从而可以显著的提高疏水性药物的口服吸收。
Oral absorption of hydrophobic drugs can be significantly improved using lipid-based non-particulate drug delivery systems, which avoid the dissolution step.
利用非微粒脂质给药系统，药物不必经过溶出的步骤，从而可以显著的提高疏水性药物的口服吸收。
Oral absorption of hydrophobic drugs can be significantly improved using lipid-based non-particulate drug delivery systems, which avoid the dissolution step.
应用推荐